Military.com Week of February 12, 2018

TRICARE beneficiaries taking certain maintenance drugs for diabetes or high cholesterol are now paying lower or no copayments as part of a pilot program. The Medication Adherence Pilot Program, launched on Feb. 1, will examine whether people are more likely to follow a medication treatment plan when those drugs are available at no-or-reduced cost. The program affects prescriptions purchased at in-network retail pharmacies and through the TRICARE Pharmacy Home Delivery. Two high-value medications were chosen for the pilot program: Lantus® Pens and Rosuvastatin, the generic version of Crestor®. Participation is automatic. The pilot program will run for up to five years.